5,508 reports of this reaction
3.6% of all VENLAFAXINE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for VENLAFAXINE, manufactured by Alembic Pharmaceuticals Inc.. There are 5,508 FDA adverse event reports linking VENLAFAXINE to DRUG INEFFECTIVE. This represents approximately 3.6% of all 151,835 adverse event reports for this drug.
VENLAFAXINE has an overall safety score of 88 out of 100. Patients taking VENLAFAXINE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among VENLAFAXINE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for VENLAFAXINE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 5,508 FDA reports for VENLAFAXINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.6% of all adverse event reports for VENLAFAXINE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking VENLAFAXINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.